chr2-1634207-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PM2BP4_StrongBP6_Very_StrongBP7BS1
The ENST00000252804.9(PXDN):c.4437C>T(p.Pro1479=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,578,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00043 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
PXDN
ENST00000252804.9 synonymous
ENST00000252804.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.36
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-1634207-G-A is Benign according to our data. Variant chr2-1634207-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 790962.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-1634207-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.36 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000427 (65/152374) while in subpopulation EAS AF= 0.0112 (58/5176). AF 95% confidence interval is 0.0089. There are 0 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PXDN | NM_012293.3 | c.4437C>T | p.Pro1479= | synonymous_variant | 23/23 | ENST00000252804.9 | NP_036425.1 | |
LOC124907723 | XR_007086188.1 | n.177G>A | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PXDN | ENST00000252804.9 | c.4437C>T | p.Pro1479= | synonymous_variant | 23/23 | 1 | NM_012293.3 | ENSP00000252804 | P1 | |
PXDN | ENST00000478155.5 | n.3525C>T | non_coding_transcript_exon_variant | 15/15 | 2 | |||||
PXDN | ENST00000493654.1 | n.1774C>T | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
PXDN | ENST00000453308.1 | c.*227C>T | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 3 | ENSP00000414098 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
65
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000839 AC: 162AN: 192980Hom.: 0 AF XY: 0.000839 AC XY: 87AN XY: 103640
GnomAD3 exomes
AF:
AC:
162
AN:
192980
Hom.:
AF XY:
AC XY:
87
AN XY:
103640
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000211 AC: 301AN: 1426472Hom.: 0 Cov.: 30 AF XY: 0.000210 AC XY: 148AN XY: 706016
GnomAD4 exome
AF:
AC:
301
AN:
1426472
Hom.:
Cov.:
30
AF XY:
AC XY:
148
AN XY:
706016
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000427 AC: 65AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.000510 AC XY: 38AN XY: 74510
GnomAD4 genome
AF:
AC:
65
AN:
152374
Hom.:
Cov.:
33
AF XY:
AC XY:
38
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
PXDN-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Anterior segment dysgenesis 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 16, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at